Table 1.
Demographic and clinical characteristics of patients who agreed and did not agree to randomization for the health information technology intervention study.
| Characteristics | Agreed to randomization (n=87) | Did not agree to randomization (n=262) | P value | |
| Age (years), mean (SD) | 58.8 (11.3) | 59.2 (11.4) | .78 | |
| Race, n (%) |
|
|
.06 | |
|
|
Caucasian | 64 (74) | 207 (79.0) |
|
|
|
African American | 15 (17) | 47 (17.9) |
|
|
|
Other | 8 (9) | 8 (3.1) |
|
| Men, n (%) | 62 (71) | 150 (57.3) | .02 | |
| Comorbidity, n (%) |
|
|
.03 | |
|
|
HCVa | 5 (6) | 28 (10.7) |
|
|
|
HCV+alcohol-related | 26 (30) | 117 (44.7) |
|
|
|
Alcohol-related | 9 (10) | 15 (5.7) |
|
|
|
NAFLDb | 25 (29) | 60 (22.9) |
|
|
|
Other | 22 (25) | 42 (16.0) |
|
| Prior HEc, n (%) | 56 (64) | 151 (57.6) | .27 | |
| Lactulose use, n (%) | 50 (57) | 152 (58.0) | .93 | |
| Rifaximin use, n (%) | 40 (46) | 101 (38.5) | .22 | |
| Taking psychoactive medications, n (%) | 12 (14) | 57 (21.8) | .09 | |
| Taking opioids, n (%) | 11 (13) | 71 (27.1) | .004 | |
| MELDd score on admission, mean (SD) | 19.5 (6.9) | 18.4 (8.4) | .24 | |
| Reason for admission, n (%) |
|
|
|
|
|
|
Infection | 29 (33) | 81 (30.9) | .68 |
|
|
HE | 38 (44) | 82 (31.3) | .03 |
|
|
Renal or metabolic disease | 29 (33) | 97 (37.0) | .58 |
|
|
Gastrointestinal bleeding | 28 (32) | 50 (19.1) | .01 |
|
|
Other | 21 (24) | 144 (55.0) | <.001 |
aHCV: hepatitis C virus.
bNAFLD: nonalcoholic fatty liver disease.
cHE: hepatic encephalopathy.
dMELD: Model for End-stage Liver Disease.